Psychiatrists’ awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa
José Manuel Olivares(University Hospital Complex Of Vigo), Schreiner(Janssen (Germany)), Lupe Martínez, Philip Gorwood(Inserm), Peter Haddad(Deakin University), Cañas, Naber(Universität Hamburg), Papageorgiou(Evangelismos Hospital), Jean‐Michel Azorin(Hôpital Sainte-Marguerite), Dubois(Cliniques Universitaires Saint-Luc), R. Emsley(Stellenbosch University), Miquel Roca(Instituto de Salud Carlos III), Thomas(Hôpital Fontmaure), Köksal Alptekın(Dokuz Eylül University)
Cited by 39
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k